Record Details

And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16294/
https://www.business-standard.com/article/current-affairs/and-now-a-seaweed-based-nutraceutical-cure-for-fatty-liver-disease-122092701121_1.html
 
Title And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022
 
Creator CMFRI, Library
 
Subject Seaweed
CMFRI News Clippings
 
Description Kochi: The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds for the treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 percent natural bioactive ingredients extracted from seaweeds to improve liver health.
 
Publisher Business Standard
 
Date 2022
 
Type Article
NonPeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16294/1/Business%20Standard_27-09-2022.pdf
CMFRI, Library (2022) And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022. Business Standard.